Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Immuneering (IMRX) Cash & Current Investments: 2020-2023

Historic Cash & Current Investments for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $85.7 million.

  • Immuneering's Cash & Current Investments fell 47.91% to $50.7 million in Q3 2024 from the same period last year, while for Sep 2024 it was $267.3 million, marking a year-over-year decrease of 33.71%. This contributed to the annual value of $85.7 million for FY2023, which is 18.82% down from last year.
  • According to the latest figures from FY2023, Immuneering's Cash & Current Investments is $85.7 million, which was down 18.82% from $105.5 million recorded in FY2022.
  • Immuneering's Cash & Current Investments' 5-year high stood at $149.2 million during FY2021, with a 5-year trough of $37.1 million in FY2020.
  • Over the past 3 years, Immuneering's median Cash & Current Investments value was $105.5 million (recorded in 2022), while the average stood at $113.5 million.
  • Its Cash & Current Investments has fluctuated over the past 5 years, first skyrocketed by 302.26% in 2021, then declined by 29.27% in 2022.
  • Immuneering's Cash & Current Investments (Yearly) stood at $37.1 million in 2020, then surged by 302.26% to $149.2 million in 2021, then decreased by 29.27% to $105.5 million in 2022, then declined by 18.82% to $85.7 million in 2023.